Traditional Chinese medicine composition for treating hepatitis B

Abstract

The invention relates to a traditional Chinese medicine composition for treating hepatitis B, comprising the following traditional Chinese medicine ingredients in parts by weight: 6-18 parts of radix bupleuri, 6-18 parts of angelica sinensis, 10-20 parts of radix paeoniae alba, 6-18 parts of rhizoma atractylodis macrocephalae, 6-18 parts of poria cocos, 5-15 parts of liquorice, 4-12 parts of mint, 6-18 parts of rhizoma cyperi, 6-18 parts of radix curcumae, 10-20 parts of rhizoma corydalis, 10-30 parts of capillary artemisia, 10-20 parts of dactylicapnos scandens, 20-40 parts of astragalus mongholicus and 6-18 parts of mangnolia officinalis. The traditional Chinese medicine composition has the effects of soothing the liver, tonifying the lung, enriching and nourishing the blood, strengthening the spleen, tonifying the qi, clearing away the heat and the toxic materials, regulating the qi, dispelling the melancholy, drying the dampness and alleviating the water retention; when being used for treating the hepatitis B, the traditional Chinese medicine composition has remarkable curative effect and reliable function; and the traditional Chinese medicine composition is wide in ingredient source, simple and convenient for preparation and free of toxic and side effects.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating hepatitis B. Background technique [0002] Hepatitis B is a disease caused by infection of the body with the hepatitis B virus (HBV). Clinical manifestations: fatigue, loss of appetite, nausea, vomiting, oily, hepatomegaly and abnormal liver function. Hepatitis B virus is a hepatotropic virus that mainly exists in liver cells and damages liver cells, causing inflammation, necrosis, and fibrosis of liver cells. At present, it is believed that the pathogenesis of hepatitis B is closely related to the immune response of the body. It is generally believed that after the hepatitis B virus invades the human body, the virus itself does not directly cause liver cell lesions, but only uses the nutrients absorbed by the liver cells to survive and develop in the liver cells. copy within. The...

AI Technical Summary

Problems solved by technology

At present, there is no drug to completely cure hepatitis B, and its treatment is mainly antiviral therapy. Commonly used antiviral drugs mainly include: interferon, lamivudine, adefovir, and entecavir.